Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis

The proper dose and schedule of sunitinib have yet to be established for patients with metastatic renal cell carcinoma (RCC) on hemodialysis. We reviewed two patients with metastatic RCC on hemodialysis who had been treated with sunitinib in Yonsei Cancer Center, Yonsei University College of Medicin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yoon, Sang Hyun, Kim, Ki Hyang, Choi, Junjeong, Kim, Gun Min, Kim, Joo Hoon, Kim, Hyo Song, Park, Young Nyun, Rha, Sun Young
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2010
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2953783/
https://ncbi.nlm.nih.gov/pubmed/20948925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2010.42.3.180
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados